In the early 2000s, Mr. Ahmed founded Nexus Pharmaceuticals, a U.S.-based specialty pharmaceutical company focused on developing and manufacturing critical-need injectable medications. Under his leadership, the company grew to over 200 employees and successfully built a greenfield, state-of-the-art parenteral manufacturing facility, solidifying Nexus’s role as a key player in sterile drug production.

Before founding Nexus, Mr. Ahmed held leadership positions at American Pharmaceutical Partners and Ben Venue Laboratories, where he was responsible for securing FDA approval of more than 90 Abbreviated New Drug Applications (ANDAs) and one New Drug Application (NDA).

He holds a Master of Science in Analytical Chemistry from the University of Manitoba and is widely recognized for his expertise in analytical chemistry and regulatory affairs. Mr. Ahmed is also the holder of three U.S. patents in pharmaceutical innovation.